| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CNMD | Common Stock | Options Exercise | $0 | +1,250 | +17% | $0.000000 | 8,625 | 01 Mar 2022 | Direct | |
| transaction | CNMD | Common Stock | Tax liability | $56,953 | -394 | -4.6% | $144.55 | 8,231 | 01 Mar 2022 | Direct | |
| transaction | CNMD | Common Stock | Options Exercise | $0 | +1,250 | +15% | $0.000000 | 9,481 | 01 Mar 2022 | Direct | |
| transaction | CNMD | Common Stock | Tax liability | $53,050 | -367 | -3.9% | $144.55 | 9,114 | 01 Mar 2022 | Direct | |
| transaction | CNMD | Common Stock | Options Exercise | $0 | +1,050 | +12% | $0.000000 | 10,164 | 01 Mar 2022 | Direct | |
| transaction | CNMD | Common Stock | Tax liability | $44,666 | -309 | -3% | $144.55 | 9,855 | 01 Mar 2022 | Direct | |
| transaction | CNMD | Common Stock | Options Exercise | $209,650 | +5,000 | +51% | $41.93 | 14,855 | 02 Mar 2022 | Direct | |
| transaction | CNMD | Common Stock | Sale | $727,500 | -5,000 | -34% | $145.50 | 9,855 | 02 Mar 2022 | Direct | |
| transaction | CNMD | Common Stock | Options Exercise | $18,468 | +308 | +3.1% | $59.96 | 10,163 | 02 Mar 2022 | Direct | |
| transaction | CNMD | Common Stock | Sale | $44,814 | -308 | -3% | $145.50 | 9,855 | 02 Mar 2022 | Direct | |
| transaction | CNMD | Common Stock | Options Exercise | $8,664 | +110 | +1.1% | $78.76 | 9,965 | 02 Mar 2022 | Direct | |
| transaction | CNMD | Common Stock | Sale | $16,005 | -110 | -1.1% | $145.50 | 9,855 | 02 Mar 2022 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CNMD | Rsus (restricted Stock Units) | Options Exercise | $0 | -1,250 | -50% | $0.000000 | 1,250 | 01 Mar 2022 | Common Stock | 1,250 | $0.000000 | Direct | F1 |
| transaction | CNMD | Rsus (restricted Stock Units) | Options Exercise | $0 | -1,250 | -33% | $0.000000 | 2,500 | 01 Mar 2022 | Common Stock | 1,250 | $0.000000 | Direct | F1 |
| transaction | CNMD | Rsus (restricted Stock Units) | Options Exercise | $0 | -1,050 | -25% | $0.000000 | 3,150 | 01 Mar 2022 | Common Stock | 1,050 | $0.000000 | Direct | F1 |
| transaction | CNMD | Options To Purchase Common Stock | Options Exercise | $0 | -5,000 | -100% | $0.000000* | 0 | 02 Mar 2022 | Common Stock | 5,000 | $41.93 | Direct | F2 |
| transaction | CNMD | Options To Purchase Common Stock | Options Exercise | $0 | -308 | -2.9% | $0.000000 | 10,492 | 02 Mar 2022 | Common Stock | 308 | $59.96 | Direct | F2 |
| transaction | CNMD | Options To Purchase Common Stock | Options Exercise | $0 | -110 | -1.9% | $0.000000 | 5,590 | 02 Mar 2022 | Common Stock | 110 | $78.76 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. |
| F2 | The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |
| F3 | The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period |